Companies / Spain
Biotech Facing Financial, Regulatory Challenges
November 2006 | Company Finance AlertAccording to Genoma Espana - a government-industry forum promoting Spain's biotechnology industry - venture capitalists remain wary of investing in local companies that are active in the field. The amount of investment in biotech provided by venture capitalists, who often play a key role in providing start-up finance in the US, amounted to little more than EUR25mn (US$32mn) in 2000 through 2004. By contrast, biotech projects in the US attracted over US$2.6bn in venture capital funding in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
